HOME | CONTACT | SITE MAP |
  • ABOUT HGS
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • RESEARCH & DEVELOPMENT
      • > Human Antibody Technology
      • > Albumin-Fusion Technology
      • > Drug Development at HGS
    • MANUFACTURING
    • HGS EUROPE
    • CALENDAR OF EVENTS
    • INTERNET PRIVACY POLICY
    • LEGAL NOTICES
    • GRANTS AND RESEARCH
    • CONTACTS
  • PIPELINE
    • BENLYSTA
    • Raxibacumab
    • Mapatumumab
    • GSK Products
    • CONTACTS
  • PARTNERS
    • LEAD COMMERCIAL COLLABORATIONS
    • PRODUCT COLLABORATIONS
    • TECHNOLOGY COLLABORATIONS
    • CONTACTS
  • INVESTORS
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • CORPORATE GOVERNANCE
      • > Audit Committee
      • > Compensation Committee
      • > Nominating and Governance Committee
      • > Code of Ethics and Business Conduct
      • > Finance Committee
      • > Comprehensive Compliance Program
    • CALENDAR OF EVENTS
    • ANNUAL MEETING
    • CORPORATE PRESENTATION
    • ANNUAL REPORTS
    • QUARTERLY RESULTS
    • SEC FILINGS
    • INSIDER TRANSACTIONS
    • ANALYST COVERAGE
    • TRANSFER AGENT
    • EMAIL ALERTS
    • INVESTOR RELATIONS CONTACT
  • NEWS
    • NEWS RELEASES
    • CALENDAR OF EVENTS
    • EMAIL ALERTS
    • MEDIA CONTACT
  • CAREERS
    • SEARCH FOR JOBS
      • Guidelines to Apply
    • WORK & LIFE AT HGS
    • DIVERSITY
    • BENEFITS
    • RECRUITER INFORMATION
Human Genome Sciences
  • NEWS
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • CALENDAR OF EVENTS
  • EMAIL ALERTS
  • MEDIA CONTACT

2012 NEWS RELEASES

January 9, 2012

HUMAN GENOME SCIENCES REPORTS PROGRESS WITH COMMERCIALIZATION OF BENLYSTA® AND ANNOUNCES 2012 GOALS AT JPMORGAN HEALTHCARE CONFERENCE

January 5, 2012

HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT J.P. MORGAN HEALTHCARE CONFERENCE

[ Back ]

©2012 Human Genome Sciences, Inc.

Human Genome Sciences | 14200 Shady Grove Road | Rockville, MD 20850
P. 301.309.8504 | F. 301.309.8512